US Patent Issued to BIONTECH CELL & GENE THERAPIES, TRON-TRANSLATIONALE ONKOLOGIE AN UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GE, ASTELLAS PHARMA on Feb. 24 for "Claudin-6-specific immunoreceptors and T cell epitopes" (German Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,531, issued on Feb. 24, was assigned to BIONTECH CELL & GENE THERAPIES GMBH (Mainz, Germany), TRON-TRANSLATIONALE ONKOLOGIE AN UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GE (Mainz, Germany) and ASTELLAS PHARMA INC. (Tokyo).

"Claudin-6-specific immunoreceptors and T cell epitopes" was invented by Ugur Sahin (Mainz, Germany), Ozlem Tureci (Mainz, Germany), Petra Simon (Mainz, Germany), Tana Omokoko (Mainz, Germany), Holger Hoff (Mainz, Germany), Ralf-Holger Voss (Ingelheim, Germany), Andrea Breitkreuz (Worms, Germany), Kathleen Hobohm (Kelkheim i. Ts, Germany) and Karolina Anna Mroz (Wiesbaden, Germany).

According to the abstract* released by the U.S. Patent & Tra...